Condition: Parkinson Disease
Interventions: Drug: safinamide metansolfonato (12 weeks); Drug: rasagilina mesilato (12 weeks)
Sponsors: Universita di Verona; Azienda Ospedaliera Universitaria Integrata Verona
Recruiting
https://ift.tt/2BSKbHG
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
-
http://bit.ly/2SylJiJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου